Morbidity, mortality and long-term sequelae of West Nile virus disease in Québec

Epidemiology and Infection

Volumn 146, Issue 7, 2018, Pages 867-874

  Ouhoumanne, N ^a   Lowe, A M ^a   Fortin, A ^a   Kairy, D ^b,c   Vibien, A ^d   K Lensch, J ^d   Tannenbaum, T N ^e   Milord, F ^a,f  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CENTRE FOR INTERDISCIPLINARY RESEARCH IN REHABILITATION OF GREATER MONTREAL   (Canada)

^d Department of Pharmacy   (Canada)

^e Gouvernement du Quebec   (Canada)

^f UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Morbidity mortality; sequelae; West Nile virus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISABILITY; DISEASE SEVERITY; ENCEPHALITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MENTAL HEALTH; MORBIDITY; MORTALITY; PROGNOSIS; QUEBEC; SOCIAL INTERACTION; VERY ELDERLY; WEST NILE FEVER; WEST NILE VIRUS; COMPLICATION; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PROSPECTIVE STUDIES; QUEBEC; SEVERITY OF ILLNESS INDEX; WEST NILE FEVER; WEST NILE VIRUS; YOUNG ADULT;

EID: 85044444193     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268818000687     Document Type: Article

References (33)

1. Centres for Disease Control and Prevention (2017) West Nile virus: Statistics & Maps. Available at https://www.cdc.gov/westnile/statsmaps/index.html. (Accessed 15 May 2017).
2. Public Health Agency of Canada (2017) Surveillance of West Nile virus. Available at https://www.canada.ca/en/public-health/services/diseases/westnile-virus/surveillance-west-nile-virus.html#s1. (Accessed 15 May 2017).
3. Ouhoummane N, et al. West Nile Virus Infection Surveillance in Québec: 2013 season. Institut national de santé publique du Québec 2015, pp. 51, Available at https://www.inspq.qc.ca/publications/4143.
4. Carson PJ, et al. (2012) Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerging Infectious Diseases 18, 684-686.
5. Mostashari F, et al. (2001) Epidemic West Nile encephalitis, New York, 1999: Results of a household-based seroepidemiological survey. Lancet London England 358, 261-264.
6. Lindsey NP, et al. (2012) Medical risk factors for severe West Nile virus disease, United States, 2008-2010. American Journal of Tropical Medicine and Hygiene 87, 179-184.
7. Murray K, et al. (2006) Risk factors for encephalitis and death from West Nile virus infection. Epidemiology and Infection 134, 1325-1332.
8. Murray KO, et al. (2009) Risk factors for encephalitis fromWest Nile virus: A matched case-control study using hospitalized controls. Zoonoses Public Health 56, 370-375.
9. Ferrouillet C, et al. (2012) Surveillance de l'infection par le virus du Nil occidental au Québec: Saison 2012. Institut national de santé publique du Québec 2014, pp 51. Available at https://www.inspq.qc.ca/publications/1747.
10. Sejvar JJ (2014) Clinical manifestations and outcomes of West Nile virus infection. Viruses 6, 606-623.
11. Pepperell C, et al. (2003)West Nile virus infection in 2002: Morbidity and mortality among patients admitted to hospital in southcentral Ontario. Canadian Medical Association Journal 168, 1399-1405.
12. Klee AL, et al. (2004) Long-term prognosis for clinical West Nile virus infection. Emerging Infectious Diseases 10, 1405-1411.
13. Murray KO, et al. (2014) Survival analysis, long-term outcomes., percentage of recovery up to 8 years post-infection among the Houston West Nile virus cohort. PLoS ONE 9, e102953.
14. Patel H, Sander B and Nelder MP (2015) Long-term sequelae of West Nile virus-related illness: A systematic review. Lancet Infectious Disease 15, 951-959.
15. Gosselin P, et al. (2005) The Integrated System for Public Health Monitoring of West Nile Virus (ISPHM-WNV): A real-time GIS for surveillance and decision-making. International Journal of Health Geographics 4, 21.
16. Comité d'éthique de santé publique (2014) Avis sur le projet d'étude du fardeau de l'infection par le VNO au Québec: Cohortes 2012 et 2013. Institut national de santé publique du Québec 2014, pp 2, Available at https://www.inspq.qc.ca/publications/1751.
17. Saris-Baglama RN, et al. (2010) QualityMetric Health Outcomes™ Scoring Software 4.0. Lincoln, RI: QualityMetric Inc.
18. Hopman WM, et al. (2000) Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. Canadian Medical Association Journal 163, 265-271.
19. Lawton MP and Brody EM (1969) Assessment of older people: Selfmaintaining and instrumental activities of daily living. The Gerontologist 9, 179-186.
20. Ministère de la santé et des services sociaux du Québec (2016) Surveillance des maladies à déclaration obligatoire au Québec-Maladie d'origine infectieuse-Définitions nosologiques 10e édition 2016, pp. 120, Available at http://publications.msss.gouv.qc.ca/msss/fichiers/2016/16-268-03W.pdf.
21. Hays RD, et al. (1996) A microcomputer program (sf36. exe) that generates SAS Code for scoring the SF-36 Health Survey.
22. Maruish ME (ed.) (2011) User's manual for the SF-36 vs health survey, 3rd edn. LincoIn, RI: QualityMetric Incorporated.
23. Racsa L, et al. (2014) Clinical features of West Nile virus epidemic in Dallas, Texas, 2012. Diagnostic Microbiology and Infectious Disease 78, 132-136.
24. Gottfried K, Quinn R and Jones T (2005) Clinical description and follow-up investigation of human West Nile virus cases. Southern Medical Journal 98, 603-606.
25. Loeb M, et al. (2008) Prognosis after West Nile virus infection. Annals of Internal Medicine 149, 232-241.
26. Weatherhead JE, et al. (2015) Long-term neurological outcomes in West Nile virus-infected patients: An observational study. American Journal of Tropical Medicine and Hygiene 92, 1006-1012.
27. Murray KO, et al. (2008) Clinical investigation of hospitalized human cases of West Nile virus infection in Houston, Texas, 2002-2004. Vector-Borne and Zoonotic Diseases 8, e167-174.
28. Watson JT, et al. (2004) Clinical characteristics and functional outcomes of West Nile fever. Annals of Internal Medicine 141, 360-365.
29. Sejvar JJ, et al. (2006) West Nile virus-Associated flaccid paralysis outcome. Emerging Infectious Diseases 12, 514-516.
30. Johnstone J, et al. (2011) Prognosis of West Nile virus associated acute flaccid paralysis: A case series. Journal of Medical Case Reports 5, 395.
31. Sejvar JJ, et al. (2008) Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. Journal of Neuropsychology 2, 477-499.
32. Sejvar JJ, et al. (2003) Neurologic manifestations and outcome of West Nile virus infection. Journal of the American Medical Association 290, 511-515.
33. Carson PJ, et al. (2006) Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clinical Infectious Diseases 43, 723-730.